The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
The MC4 receptor and control of appetite
Open accessAbstract
Mutations in the human melanocortin (MC)4 receptor have been associated with obesity, which underscores the relevance of this receptor as a drug target to treat obesity. Infusion of MC4R agonists decreases food intake, whereas inhibition of MC receptor activity by infusion of an MC receptor antagonist or with the inverse agonist AgRP results in increased food intake. This review addresses the role of the MC system in different aspects of feeding behaviour. MC4R activity affects meal size and meal choice, but not meal frequency, and the type of diet affects the efficacy of MC4R agonists to reduce food intake. The central sites involved in the different aspects of feeding behaviour that are affected by MC4R signalling are being unravelled. The paraventricular nucleus plays an important role in food intake per se, whereas MC signalling in the lateral hypothalamus is associated with the response to a high fat diet. MC4R signalling in the brainstem has been shown to affect meal size. Further genetic, behavioural and brain‐region specific studies need to clarify how the MC4R agonists affect feeding behaviour in order to determine which obese individuals would benefit most from treatment with these drugs. Application of MCR agonists in humans has already revealed side effects, such as penile erections, which may complicate introduction of these drugs in the treatment of obesity. British Journal of Pharmacology (2006) 149, 815–827. doi:10.1038/sj.bjp.0706929
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Abnormal splicing of the leptin receptor in diabetic mice
Lee, G.-H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996) · Nature · doi:10.1038/379632a0 · Cited by 2,327
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., & Cone, R. D. (1997) · Nature · doi:10.1038/385165a0 · Cited by 1,902
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997) · Science · doi:10.1126/science.278.5335.135 · Cited by 1,881
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O'Rahilly, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022050 · Cited by 1,778
Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., & Grüters, A. (1998) · Nature Genetics · doi:10.1038/509 · Cited by 1,733
Anatomy and regulation of the central melanocortin system
Cone, R. D. (2005) · Nature Neuroscience · doi:10.1038/nn1455 · Cited by 1,583
Mountjoy, K. G. (1994) · Molecular Endocrinology · doi:10.1210/me.8.10.1298 · Cited by 1,156
NPY/AgRP Neurons Are Essential for Feeding in Adult Mice but Can Be Ablated in Neonates
Luquet, S., Perez, F. A., Hnasko, T. S., & Palmiter, R. D. (2005) · Science · doi:10.1126/science.1115524 · Cited by 1,125
Ghrelin Causes Hyperphagia and Obesity in Rats
Wren, A. M., Small, C. J., Abbott, C. R., Dhillo, W. S., Seal, L. J., Cohen, M. A., Batterham, R. L., Taheri, S., Stanley, S. A., Ghatei, M. A., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2540 · Cited by 1,121
Divergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure
Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., Williams, T., Ferreira, M., Tang, V., McGovern, R. A., Kenny, C. D., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.035 · Cited by 1,120
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.
Halaas, J. L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D. A., & Friedman, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8878 · Cited by 1,033
Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
Yaswen, L., Diehl, N., Brennan, M. B., & Hochgeschwender, U. (1999) · Nature Medicine · doi:10.1038/12506 · Cited by 1,012
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., & Froguel, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9238 · Cited by 897 · cited 3×
“5% with a highest prevalence of 6% among severe obese children (Vaisse et al., 2000; Farooqi et al., 2003; Larsen et al., 2005; Hinney et al., 2006).”
BackgroundInfluentialChen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X.-M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L., et al. (2000) · Nature Genetics · doi:10.1038/79254 · Cited by 894
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887
Leptin Increases Hypothalamic Pro-opiomelanocortin mRNA Expression in the Rostral Arcuate Nucleus
Schwartz, M. W., Seeley, R. J., Woods, S. C., Weigle, D. S., Campfield, L. A., Burn, P., & Baskin, D. G. (1997) · Diabetes · doi:10.2337/diab.46.12.2119 · Cited by 879
ROBBINS, L. (1993) · Cell · doi:10.1016/0092-8674(93)90572-8 · Cited by 876
Glenn Stanley, B., Kyrkouli, S. E., Lampert, S., & Leibowitz, S. F. (1986) · Peptides · doi:10.1016/0196-9781(86)90149-x · Cited by 849
Farooqi, I. S., Yeo, G. S. H., Keogh, J. M., Aminian, S., Jebb, S. A., Butler, G., Cheetham, T., & O’Rahilly, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9397 · Cited by 815
Genetics of body-weight regulation
Barsh, G. S., Farooqi, I. S., & O'Rahilly, S. (2000) · Nature · doi:10.1038/35007519 · Cited by 778
Roselli-Rehfuss, L., Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., Low, M. J., Tatro, J. B., Entwistle, M. L., Simerly, R. B., & Cone, R. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8856 · Cited by 720
A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse
Butler, A. A., Kesteson, R. A., Khong, K., Cullen, M. J., Pelleymounter, M. A., DeKoning, J., Baetscher, M., & Cone, R. D. (2000) · Endocrinology · doi:10.1210/en.141.9.3518 · Cited by 701
Integration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular Nucleus
Cowley, M. A., Pronchuk, N., Fan, W., Dinulescu, D. M., Colmers, W. F., & Cone, R. D. (1999) · Neuron · doi:10.1016/s0896-6273(00)80829-6 · Cited by 617
Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat
Kishi, T., Aschkenasi, C. J., Lee, C. E., Mountjoy, K. G., Saper, C. B., & Elmquist, J. K. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10454 · Cited by 581
Rossi, M., Kim, M. S., Morgan, D. G. A., Small, C. J., Edwards, C. M. B., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A., et al. (1998) · Endocrinology · doi:10.1210/endo.139.10.6332 · Cited by 576 · cited 1×
“A single central administration of AgRP increases food intake for at least 24 h (up to 7 days) and blocks a-MSH/MTII-induced hypophagia (Rossi et al., 1998; Hagan et al., 2000; Wirth and Giraudo, 2000).”
BackgroundResponse of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides
Marsh, D. J., Hollopeter, G., Huszar, D., Laufer, R., Yagaloff, K. A., Fisher, S. L., Burn, P., & Palmiter, R. D. (1999) · Nature Genetics · doi:10.1038/5070 · Cited by 542
Stegmeier, F., Hu, G., Rickles, R. J., Hannon, G. J., & Elledge, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506306102 · Cited by 532
Mizuno, T. M., Kleopoulos, S. P., Bergen, H. T., Roberts, J. L., Priest, C. A., & Mobbs, C. V. (1998) · Diabetes · doi:10.2337/diab.47.2.294 · Cited by 521
Gantz, I., & Fong, T. M. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00434.2002 · Cited by 466
Farooqi, I. S., & O'Rahilly, S. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144924 · Cited by 440
Targeting melanocortin receptors as a novel strategy to control inflammation
Catania, A., Gatti, S., Colombo, G., & Lipton, J. M. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.1.1 · Cited by 438
Qian, S., Chen, H., Weingarth, D., Trumbauer, M. E., Novi, D. E., Guan, X., Yu, H., Shen, Z., Feng, Y., Frazier, E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5027-5035.2002 · Cited by 430
AgRP(83-132) Acts as an Inverse Agonist on the Human-Melanocortin-4 Receptor
Nijenhuis, W. A. J. (2001) · Molecular Endocrinology · doi:10.1210/me.15.1.164 · Cited by 406
Gispen, W. H., Wiegant, V. M., Greven, H. M., & de Wied, D. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90103-4 · Cited by 374
A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors
Ste. Marie, L., Miura, G. I., Marsh, D. J., Yagaloff, K., & Palmiter, R. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220409497 · Cited by 366
Harris, M., Aschkenasi, C., Elias, C. F., Chandrankunnel, A., Nillni, E. A., Bjørbæk, C., Elmquist, J. K., Flier, J. S., & Hollenberg, A. N. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10741 · Cited by 341
Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat
Butler, A. A., Marks, D. L., Fan, W., Kuhn, C. M., Bartolome, M., & Cone, R. D. (2001) · Nature Neuroscience · doi:10.1038/88423 · Cited by 332
How Palatable Food Disrupts Appetite Regulation
Erlanson‐Albertsson, C. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_179.x · Cited by 330 · cited 2×
“Even when a high degree of satiety is achieved, the availability of a highly palatable food may overrule this and increase meal size (Erlanson-Albertsson, 2005).”
BackgroundHagan, M. M., Rushing, P. A., Pritchard, L. M., Schwartz, M. W., Strack, A. M., Van der Ploeg, L. H. T., Woods, S. C., & Seeley, R. J. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.1.r47 · Cited by 320
New aspects on the melanocortins and their receptors
Wikberg, J. E. S., Muceniece, R., Mandrika, I., Prusis, P., Lindblom, J., Post, C., & Skottner, A. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0725 · Cited by 319
Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system
Fan, W., Ellacott, K. L. J., Halatchev, I. G., Takahashi, K., Yu, P., & Cone, R. D. (2004) · Nature Neuroscience · doi:10.1038/nn1214 · Cited by 307
Krude, H., Biebermann, H., Schnabel, D., Tansek, M. Z., Theunissen, P., Mullis, P. E., & Grüters, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030502 · Cited by 307
Haynes, A. C., Jackson, B., Overend, P., Buckingham, R. E., Wilson, S., Tadayyon, M., & Arch, J. R. S. (1999) · Peptides · doi:10.1016/s0196-9781(99)00105-9 · Cited by 306
A role for the melanocortin 4 receptor in sexual function
Van der Ploeg, L. H. T., Martin, W. J., Howard, A. D., Nargund, R. P., Austin, C. P., Guan, X., Drisko, J., Cashen, D., Sebhat, I., Patchett, A. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172378699 · Cited by 303
Challis, B. G. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1997 · Cited by 288
Grill, H. J., Ginsberg, A. B., Seeley, R. J., & Kaplan, J. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10128.1998 · Cited by 278
Mind versus metabolism in the control of food intake and energy balance
BERTHOUD, H. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.04.034 · Cited by 259
Haskell-Luevano, C., & Monck, E. K. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00234-8 · Cited by 252
Control of Food Intake in the Obese
Blundell, J. E., & Gillett, A. (2001) · Obesity Research · doi:10.1038/oby.2001.129 · Cited by 248
Role of the melanocortin-4 receptor in metabolic rate and food intake in mice
Chen, A. S., Metzger, J. M., Trumbauer, M. E., Guan, X.-M., Yu, H., Frazier, E. G., Marsh, D. J., Forrest, M. J., Gopal-Truter, S., Fisher, J., et al. (2000) · Transgenic Research · doi:10.1023/a:1008983615045 · Cited by 247
Yeo, G. S. H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.5.561 · Cited by 242
Lu, X.-Y., Barsh, G. S., Akil, H., & Watson, S. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07863.2003 · Cited by 241
Lubrano-Berthelier, C., Dubern, B., Lacorte, J.-M., Picard, F., Shapiro, A., Zhang, S., Bertrais, S., Hercberg, S., Basdevant, A., Clement, K., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1411 · Cited by 241
Peptide YY3–36Inhibits Food Intake in Mice through a Melanocortin-4 Receptor-Independent Mechanism
Halatchev, I. G., Ellacott, K. L. J., Fan, W., & Cone, R. D. (2004) · Endocrinology · doi:10.1210/en.2003-1754 · Cited by 237
Srinivasan, S., Lubrano-Berthelier, C., Govaerts, C., Picard, F., Santiago, P., Conklin, B. R., & Vaisse, C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421927 · Cited by 235
A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance
Lee, Y. S., Challis, B. G., Thompson, D. A., Yeo, G. S. H., Keogh, J. M., Madonna, M. E., Wraight, V., Sims, M., Vatin, V., Meyre, D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.006 · Cited by 234
Kim, M. S., Rossi, M., Abusnana, S., Sunter, D., Morgan, D. G., Small, C. J., Edwards, C. M., Heath, M. M., Stanley, S. A., Seal, L. J., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.2.177 · Cited by 216
Reduction of food intake and body weight by chronic intraventricular insulin infusion
Brief, D. J., & Davis, J. D. (1984) · Brain Research Bulletin · doi:10.1016/0361-9230(84)90174-6 · Cited by 212
Role of the CNS Melanocortin System in the Response to Overfeeding
Hagan, M. M., Rushing, P. A., Schwartz, M. W., Yagaloff, K. A., Burn, P., Woods, S. C., & Seeley, R. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02362.1999 · Cited by 210
Effects of Hypothalamic Neurodegeneration on Energy Balance
Xu, A. W., Kaelin, C. B., Morton, G. J., Ogimoto, K., Stanhope, K., Graham, J., Baskin, D. G., Havel, P., Schwartz, M. W., & Barsh, G. S. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030415 · Cited by 210
Hinney, A., Bettecken, T., Tarnow, P., Brumm, H., Reichwald, K., Lichtner, P., Scherag, A., Nguyen, T. T., Schlumberger, P., Rief, W., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2056 · Cited by 209
Chronic intracerebroventricular infusion of MCH causes obesity in mice
Gomori, A., Ishihara, A., Ito, M., Mashiko, S., Matsushita, H., Yumoto, M., Ito, M., Tanaka, T., Tokita, S., Moriya, M., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00350.2002 · Cited by 209
Vijayan, E., & McCann, S. M. (1977) · Endocrinology · doi:10.1210/endo-100-6-1727 · Cited by 204
Amylin: A Novel Action in the Brain to Reduce Body Weight
Rushing, P. A. (2000) · Endocrinology · doi:10.1210/en.141.2.850 · Cited by 201
Zheng, H., Patterson, L. M., Phifer, C. B., & Berthoud, H.-R. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00869.2004 · Cited by 196
Molecular Cloning and Characterisation of the Rat Fifth Melanocortin Receptor
Griffon, N., Mignon, V., Facchinetti, P., Diaz, J., Schwartz, J. C., & Sokoloff, P. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1550 · Cited by 195
The melanocortin system and energy balance
Butler, A. A. (2006) · Peptides · doi:10.1016/j.peptides.2005.02.029 · Cited by 194
Melanocortin receptors: perspectives for novel drugs
Wikberg, J. E. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00298-8 · Cited by 190
Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands
Giraudo, S. Q., Billington, C. J., & Levine, A. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00837-3 · Cited by 189
A role for β-melanocyte-stimulating hormone in human body-weight regulation
Biebermann, H., Castañeda, T. R., van Landeghem, F., von Deimling, A., Escher, F., Brabant, G., Hebebrand, J., Hinney, A., Tschöp, M. H., Grüters, A., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.007 · Cited by 185
Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations
Lubrano-Berthelier, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg016 · Cited by 184
Williams, D. L., Kaplan, J. M., & Grill, H. J. (2000) · Endocrinology · doi:10.1210/en.141.4.1332 · Cited by 183
Larsen, L. H., Echwald, S. M., Sørensen, T. I. A., Andersen, T., Wulff, B. S., & Pedersen, O. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0497 · Cited by 176
Strubbe, J. H., & Woods, S. C. (2004) · Psychological Review · doi:10.1037/0033-295x.111.1.128 · Cited by 170
Major pharmacological distinction of the ACTH receptor from other melanocortin receptors
Schiöth, H. B., Chhajlani, V., Muceniece, R., Klusa, V., & Wikberg, J. E. S. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00370-0 · Cited by 167
Acetylation alters the feeding response to MSH and beta-endorphin
Tsujii, S., & Bray, G. A. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90142-1 · Cited by 161
Small, C. J., Kim, M. S., Stanley, S. A., Mitchell, J. R. D., Murphy, K. G., Morgan, D. G. A., Ghatei, M. A., & Bloom, S. R. (2001) · Diabetes · doi:10.2337/diabetes.50.2.248 · Cited by 158
McMinn, J. E., Wilkinson, C. W., Havel, P. J., Woods, S. C., & Schwartz, M. W. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.2.r695 · Cited by 157
Bhardwaj, R. S., Becher, E., Mahnke, K., HARTMEYER, M., Schwarz, T., Scholzen, T. E., & Luger, T. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3378 · Cited by 155
Consumption of a high-fat diet alters the homeostatic regulation of energy balance
Woods, S. C., D’Alessio, D. A., Tso, P., Rushing, P. A., Clegg, D. J., Benoit, S. C., Gotoh, K., Liu, M., & Seeley, R. J. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.07.026 · Cited by 155
Sutton, G. M., Duos, B., Patterson, L. M., & Berthoud, H. (2005) · Endocrinology · doi:10.1210/en.2005-0562 · Cited by 152
Makimura, H., Mizuno, T. M., Mastaitis, J. W., Agami, R., & Mobbs, C. V. (2002) · BMC Neuroscience · doi:10.1186/1471-2202-3-18 · Cited by 150
Opioid receptor involvement in the effect of AgRP- (83–132) on food intake and food selection
Hagan, M. M., Rushing, P. A., Benoit, S. C., Woods, S. C., & Seeley, R. J. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.3.r814 · Cited by 143
Effects of Recombinant Agouti-Signaling Protein on Melanocortin Action
Yang, Y.-K., Ollmann, M. M., Wilson, B. D., Dickinson, C. J., Yamada, T., Barsh, G. S., & Gantz, I. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.3.9898 · Cited by 141
Getting, S. J., Gibbs, L., Clark, A., Flower, R. J., & Perretti, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7446 · Cited by 137
Expression of melanocortin 1 receptor in periaqueductal gray matter
Xia, Y., Wikberg, J. E. S., & Chhajlani, V. (1995) · Neuroreport · doi:10.1097/00001756-199511000-00022 · Cited by 137
Brain Melanocortin Receptors: From Cloning to Function
Adan, R. A. H., & Gispen, W. H. (1997) · Peptides · doi:10.1016/s0196-9781(97)00078-8 · Cited by 135
Self-citationDiamond, L. E., Earle, D. C., Rosen, R., Willett, M. S., & Molinoff, P. B. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901139 · Cited by 133
Agouti-related protein-deficient mice display an age-related lean phenotype
Wortley, K. E., Anderson, K. D., Yasenchak, J., Murphy, A., Valenzuela, D., Diano, S., Yancopoulos, G. D., Wiegand, S. J., & Sleeman, M. W. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.11.004 · Cited by 128
Melanocortin ligands: 30 years of structure–activity relationship (SAR) studies
Holder, J. R., & Haskell‐Luevano, C. (2004) · Medicinal Research Reviews · doi:10.1002/med.10064 · Cited by 125
The anorectic effects of CRH and restraint stress decrease with repeated exposures
Krahn, D. D., Gosnell, B. A., & Majchrzak, M. J. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90046-5 · Cited by 122
Marsh, D. J., Miura, G. I., Yagaloff, K. A., Schwartz, M. W., Barsh, G. S., & Palmiter, R. D. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01962-9 · Cited by 119
The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R)
Marks, D. L., Hruby, V. J., Brookhart, G., & Cone, R. D. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.025 · Cited by 117
Poor Cell Surface Expression of Human Melanocortin-4 Receptor Mutations Associated with Obesity
Nijenhuis, W. A. J., Garner, K. M., van Rozen, R. J., & Adan, R. A. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211326200 · Cited by 115
Self-citationWirth, M. M., Olszewski, P. K., Yu, C., Levine, A. S., & Giraudo, S. Q. (2001) · Peptides · doi:10.1016/s0196-9781(00)00367-3 · Cited by 115
Smart, J. L., Tolle, V., & Low, M. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25243 · Cited by 114
Adage, T., Scheurink, A. J. W., de Boer, S. F., de Vries, K., Konsman, J. P., Kuipers, F., Adan, R. A. H., Baskin, D. G., Schwartz, M. W., & van Dijk, G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03639.2001 · Cited by 106 · cited 3×
“Application of the MC 3/4 receptor antagonist SHU9119 results in voluntary overfeeding, obesity and increased plasma leptin levels (Fan et al., 1997; Adage et al., 2001).”
BackgroundSelf-citationMelanocortin‐3 Receptor mRNA Expression in Pro‐Opiomelanocortin Neurones of the Rat Arcuate Nucleus
Jégou, S., Boutelet, I., & Vaudry, H. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00477.x · Cited by 101
Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure
Small, C. J., Liu, Y., Stanley, S. A., Connoley, I. P., Kennedy, A., Stock, M. J., & Bloom, S. R. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802253 · Cited by 101
Melanocortins and cardiovascular regulation
Versteeg, D. H. G., Van Bergen, P., Adan, R. A. H., & De Wildt, D. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00615-3 · Cited by 98
Self-citationCloning, expression, and tissue distribution of a fifth melanocortin receptor subtype
Fathi, Z., Iben, L. G., & Parker, E. M. (1995) · Neurochemical Research · doi:10.1007/bf00995160 · Cited by 98
The Role of Melanocortins in Adipocyte Function
Boston, B. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08666.x · Cited by 93
Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity
Smith, B. K., York, D. A., & Bray, G. A. (1994) · Peptides · doi:10.1016/0196-9781(94)90152-x · Cited by 92
Hanada, R., Nakazato, M., Matsukura, S., Murakami, N., Yoshimatsu, H., & Sakata, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2081 · Cited by 90
Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice
Blüher, S., Ziotopoulou, M., Bullen, J. W., Moschos, S. J., Ungsunan, L., Kokkotou, E. G., Maratos–Flier, E., & Mantzoros, C. S. (2004) · Diabetes · doi:10.2337/diabetes.53.1.82 · Cited by 89
Effect of centrally administered neurotensin on multiple feeding paradigms
Levine, A. S., Kneip, J. M., Grace, M. K., & Morley, J. E. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90244-7 · Cited by 82
Rohner‐Jeanrenaud, F., Craft, L. S., Bridwell, J., et al. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801863 · Cited by 81
Fekete, C., Marks, D. L., Sarkar, S., Emerson, C. H., Rand, W. M., Cone, R. D., & Lechan, R. M. (2004) · Endocrinology · doi:10.1210/en.2004-0476 · Cited by 79
Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding
Wirth, M. M., & Giraudo, S. Q. (2000) · Peptides · doi:10.1016/s0196-9781(00)00280-1 · Cited by 78
Mechanisms of Antiinflammatory Action of the Neuroimmunomodulatory Peptide α‐MSH
Lipton, J. M., & Catania, A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09576.x · Cited by 76
Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP
Zheng, H., Corkern, M. M., Crousillac, S., Patterson, L. M., Phifer, C. B., & Berthoud, H. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00019.2002 · Cited by 76
Obesity-associated mutations in the human melanocortin-4 receptor gene
MacKenzie, R. G. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.064 · Cited by 73
Kask, A., & Schiöth, H. B. (2000) · Brain Research · doi:10.1016/s0006-8993(00)03034-1 · Cited by 71
Andersen, G. N., Hägglund, M., Nagaeva, O., Frängsmyr, L., Petrovska, R., Mincheva‐Nilsson, L., & Wikberg, J. E. S. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01565.x · Cited by 71
Nicholson, J. R., Kohler, G., Schaerer, F., Senn, C., Weyermann, P., & Hofbauer, K. G. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097725 · Cited by 68
Kask, A., Rägo, L., Wikberg, J. E. S., & Schiöth, H. B. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00837-5 · Cited by 64
The melanocortin receptor MCR4 controls fat consumption
Samama, P., Rumennik, L., & Grippo, J. F. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00299-9 · Cited by 64
Thody, A. J., Cooper, M. F., Bowden, P. E., MEDDIS, D., & Shuster, S. (1976) · Journal of Endocrinology · doi:10.1677/joe.0.0710279 · Cited by 62
Increased Dietary Fat Attenuates the Anorexic Effects of Intracerebroventricular Injections of MTII
Clegg, D. J., Benoit, S. C., Air, E. L., Jackman, A., Tso, P., D’Alessio, D. A., Woods, S. C., & Seeley, R. J. (2003) · Endocrinology · doi:10.1210/en.2002-0218 · Cited by 62
A review of melanocortin receptor small molecule ligands
Todorović, A., & Haskell‐Luevano, C. (2005) · Peptides · doi:10.1016/j.peptides.2004.11.024 · Cited by 57
Kral, T. V. E. (2005) · Appetite · doi:10.1016/j.appet.2005.05.006 · Cited by 56
Neuropathic pain: a possible role for the melanocortin system?
Vrinten, D. H., Kalkman, C. J., Adan, R. A. H., & Gispen, W. H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01306-1 · Cited by 53
Self-citationWilliams, D. L., Grill, H. J., Weiss, S., Baird, J.-P., & Kaplan, J. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1022-5 · Cited by 49
Macronutrient Diet Intake of the Lethal Yellow Agouti (Ay/a) Mouse
Koegler, F. H., Schaffhauser, A. O., Mynatt, R. L., York, D. A., & Bray, G. A. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00104-3 · Cited by 49
Shaw, A. M., Irani, B. G., Moore, M. C., Haskell‐Luevano, C., & Millard, W. J. (2005) · Peptides · doi:10.1016/j.peptides.2004.12.026 · Cited by 49
Santini, F., Maffei, M., Ceccarini, G., Pelosini, C., Scartabelli, G., Rosellini, V., Chiellini, C., Marsili, A., Lisi, S., Tonacchera, M., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031175 · Cited by 49
Loos, R. J. F., Rankinen, T., Rice, T., Rao, D. C., Leon, A. S., Skinner, J. S., Bouchard, C., & Argyropoulos, G. A. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.1097 · Cited by 48
Jónsson, L., Skarphedinsson, J. O., Skúladóttir, G. V., Watanobe, H., & Schiöth, H. B. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730517 · Cited by 47
Heijboer, A. C., van den Hoek, A. M., Pijl, H., Voshol, P. J., Havekes, L. M., Romijn, J. A., & Corssmit, E. P. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1838-8 · Cited by 43
A Role for the Agouti-Related Protein Promoter in Obesity and Type 2 Diabetes
Mayfield, D. K., Brown, A. M., Page, G. P., Garvey, W. T., Shriver, M. D., & Argyropoulos, G. A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5600 · Cited by 43
Altered Hypothalamic Signaling and Responses to Food Deprivation in Rats Fed a Low‐Carbohydrate Diet
Kinzig, K. P., Scott, K. A., Hyun, J., Bi, S., & Moran, T. H. (2005) · Obesity Research · doi:10.1038/oby.2005.205 · Cited by 43
Maratos–Flier, E. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50130-6 · Cited by 39
The agouti-related protein and body fatness in humans
Argyropoulos, G., Rankinen, T., Bai, F., Rice, T., Province, M., Leon, A. S., Skinner, J., Wilmore, J., Rao, D. C., & Bouchard, C. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802201 · Cited by 34
Induction of Brain Region-Specific Forms of Obesity by Agouti
Kas, M. J., Tiesjema, B., van Dijk, G., Garner, K. M., Barsh, G. S., ter Brake, O., Verhaagen, J., & Adan, R. A. H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3442-04.2004 · Cited by 30
Self-citationLearned Meal Initiation Attenuates the Anorexic Effects of the Melanocortin Agonist MTII
Benoit, S. C., Clegg, D. J., Barrera, J. G., Seeley, R. J., & Woods, S. C. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2684 · Cited by 29
The Effect of the Melanocortin Agonist, MT-II, on the Defended Level of Body Adiposity
Seeley, R. J., Burklow, M. L., Wilmer, K. A., Matthews, C. C., Reizes, O., McOsker, C. C., Trokhan, D. P., Gross, M. C., & Sheldon, R. J. (2005) · Endocrinology · doi:10.1210/en.2004-1663 · Cited by 26
Wirth, M. M., & Giraudo, S. Q. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02087-x · Cited by 25
Schick, R., Stevens, C. W., Yaksh, T. L., et al. (1988) · Brain Research · doi:10.1016/0006-8993(88)91266-8 · Cited by 22
Melanocortinergic control of penile erection
Wessells, H., Blevins, J. E., & Vanderah, T. W. (2005) · Peptides · doi:10.1016/j.peptides.2004.11.035 · Cited by 21
Muceniece, R., Zvejniece, L., Liepinsh, E., Kirjanova, O., Baumane, L., Petrovska, R., Mutulis, F., Mutule, I., Kalvinsh, I., Wikberg, J. E. S., et al. (2006) · Peptides · doi:10.1016/j.peptides.2005.12.002 · Cited by 21
Adipose targets for obesity drug development
Boss, O., & Bergenhem, N. C. H. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.119 · Cited by 13
The melanocortin agonist melanotan II increases insulin sensitivity in OLETF rats
Banno, R., Arima, H., Sato, I., Hayashi, M., Goto, M., Sugimura, Y., Murase, T., & Oiso, Y. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.007 · Cited by 11
Cited by
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Sax, P. E., Erlandson, K. M., Lake, J. E., Mccomsey, G. A., Orkin, C., Esser, S., Brown, T. T., Rockstroh, J. K., Wei, X., Carter, C. C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz999 · Cited by 768
Cellular bioenergetics as a target for obesity therapy
Tseng, Y.-H., Cypess, A. M., & Kahn, C. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3138 · Cited by 591
The Neuroendocrine Regulation of Food Intake in Fish: A Review of Current Knowledge
Volkoff, H. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00540 · Cited by 342
Maejima, Y., Sedbazar, U., Suyama, S., Kohno, D., Onaka, T., Takano, E., Yoshida, N., Koike, M., Uchiyama, Y., Fujiwara, K., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.002 · Cited by 317
Metadata
- Authors
- Adan, R. A. H., Tiesjema, B., Hillebrand, J. J. G., la Fleur, S. E., Kas, M. J. H., & de Krom, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-12
- Volume
- 149
- Issue
- 7
- Pages
- 815-827
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2038510532
- Cited by
- 259
- References
- 149
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.